QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)
QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)
QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)
QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)
NASDAQ:BEAM

Beam Therapeutics - BEAM Short Interest Ratio & Short Volume

$66.09
+0.36 (+0.55%)
(As of 08/11/2022 12:00 AM ET)
Add
Compare
Today's Range
$65.52
$73.27
50-Day Range
$29.86
$68.48
52-Week Range
$27.77
$116.91
Volume
2.62 million shs
Average Volume
1.21 million shs
Market Capitalization
$4.64 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$106.29

Beam Therapeutics Short Interest Data

Current Short Volume
12,970,000 shares
Previous Short Volume
13,240,000 shares
Change Vs. Previous Month
-2.04%
Dollar Volume Sold Short
$816.85 million
Short Interest Ratio / Days to Cover
9.5
Last Record Date
July, 31 2022
Outstanding Shares
70,267,000 shares
Float Size
56,850,000 shares
Short Percent of Float
22.81%
Today's Trading Volume
2,620,701 shares
Average Trading Volume
1,205,715 shares
Today's Volume Vs. Average
117.36%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Beam Therapeutics ?

Sign up to receive the latest short interest report for Beam Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BEAM Short Interest Over Time

BEAM Days to Cover Over Time

BEAM Percentage of Float Shorted Over Time


Beam Therapeutics (NASDAQ:BEAM) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/202212,970,000 shares $816.85 million -2.0%22.8%9.5 $62.98
7/15/202213,240,000 shares $762.89 million +3.4%23.3%9.5 $57.62
6/30/202212,810,000 shares $495.88 million +10.2%22.6%9.4 $38.71
6/15/202211,620,000 shares $371.26 million +4.6%20.5%8.7 $31.95
5/31/202211,110,000 shares $390.85 million -4.9%19.7%9.1 $35.18
5/15/202211,680,000 shares $414.06 million +8.1%21.7%9.9 $35.45
4/30/202210,810,000 shares $405.70 million +10.5%20.1%10.3 $37.53
4/15/20229,780,000 shares $453.79 million +10.9%18.5%9.3 $46.40
3/31/20228,820,000 shares $505.39 million +3.6%16.9%8.4 $57.30
3/15/20228,510,000 shares $470.09 million -3.6%16.3%9.1 $55.24
2/28/20228,830,000 shares $691.83 million +7.6%17.1%9.8 $78.35
2/15/20228,210,000 shares $606.47 million +4.7%15.9%9.5 $73.87
1/31/20227,840,000 shares $542.61 million +26.5%15.2%9.7 $69.21
1/15/20226,200,000 shares $420.48 million +11.3%11.5%8.8 $67.82
12/31/20215,570,000 shares $443.87 million +1.1%10.4%9.5 $79.69
12/15/20215,510,000 shares $443.72 million +5.6%10.2%9.3 $80.53
11/30/20215,220,000 shares $413.16 million +7.6%9.8%8.6 $79.15
11/15/20214,850,000 shares $419.23 million +3.9%9.1%8.1 $86.44
10/29/20214,670,000 shares $414.56 million -15.4%9.4%7.7 $88.77
10/15/20215,520,000 shares $514.13 million +9.5%11.2%8.7 $93.14
9/30/20215,040,000 shares $438.53 million -3.5%10.2%7.6 $87.01
9/15/20215,220,000 shares $533.01 million -5.6%10.6%6.3 $102.11
8/31/20215,530,000 shares $613.39 million +7.2%11.4%7 $110.92
8/13/20215,160,000 shares $521.26 million +2.8%10.8%6.5 $101.02
7/30/20215,020,000 shares $461.84 million +3.3%11.3%5.8 $92.00
7/15/20214,860,000 shares $415.77 million -9.0%10.9%5.6 $85.55
6/30/20215,340,000 shares $687.31 million -17.5%12.0%5.8 $128.71
6/15/20216,470,000 shares $572.34 million -2.1%15.0%8.1 $88.46
5/28/20216,610,000 shares $517.10 million -4.1%15.3%7.8 $78.23
5/14/20216,890,000 shares $455.70 million +4.7%15.1%6.8 $66.14
4/30/20216,580,000 shares $513.90 million -5.9%14.5%6.3 $78.10
4/15/20216,990,000 shares $534.39 million +3.0%17.6%6.5 $76.45
3/31/20216,790,000 shares $514.41 million +0.3%18.1%6.1 $75.76
3/15/20216,770,000 shares $666.30 million +17.1%18.9%5.9 $98.42
2/26/20215,780,000 shares $511.65 million +8.2%17.7%5 $88.52
2/12/20215,340,000 shares $558.88 million -4.3%16.4%5.2 $104.66
1/29/20215,580,000 shares $557.39 million +0.9%17.1%5.9 $99.89
1/15/20215,530,000 shares $615.60 million No Change16.8%6.1 $111.32













BEAM Short Interest - Frequently Asked Questions

What is Beam Therapeutics' current short interest?

Short interest is the volume of Beam Therapeutics shares that have been sold short but have not yet been covered or closed out. As of July 31st, traders have sold 12,970,000 shares of BEAM short. 22.81% of Beam Therapeutics' shares are currently sold short. Learn More on Beam Therapeutics' current short interest.

What is a good short interest ratio for Beam Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BEAM shares currently have a short interest ratio of 10.0. Learn More on Beam Therapeutics's short interest ratio.

Which institutional investors are shorting Beam Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Beam Therapeutics: Group One Trading L.P., JPMorgan Chase & Co., Walleye Trading LLC, Walleye Trading LLC, and Jane Street Group LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Beam Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 22.81% of Beam Therapeutics' floating shares are currently sold short.

Is Beam Therapeutics' short interest increasing or decreasing?

Beam Therapeutics saw a decrease in short interest during the month of July. As of July 31st, there was short interest totaling 12,970,000 shares, a decrease of 2.0% from the previous total of 13,240,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Beam Therapeutics' float size?

Beam Therapeutics currently has issued a total of 70,267,000 shares. Some of Beam Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Beam Therapeutics currently has a public float of 56,850,000 shares.

How does Beam Therapeutics' short interest compare to its competitors?

22.81% of Beam Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Beam Therapeutics: Denali Therapeutics Inc. (7.58%), Vir Biotechnology, Inc. (9.80%), Ginkgo Bioworks Holdings, Inc. (19.81%), Abcam plc (0.38%), Novavax, Inc. (20.90%), Halozyme Therapeutics, Inc. (6.68%), Fate Therapeutics, Inc. (23.31%), CRISPR Therapeutics AG (15.42%), Exelixis, Inc. (2.92%), and Twist Bioscience Co. (10.79%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: KLA Co. ($2.87 billion), Lucid Group, Inc. ($2.25 billion), T. Rowe Price Group, Inc. ($2.08 billion), Coinbase Global, Inc. ($1.91 billion), Williams-Sonoma, Inc. ($1.85 billion), Chesapeake Energy Co. ($1.81 billion), Rivian Automotive, Inc. ($1.64 billion), Lumen Technologies, Inc. ($1.61 billion), Plug Power Inc. ($1.50 billion), and Generac Holdings Inc. ($1.49 billion). View all of the most shorted stocks.

What does it mean to sell short Beam Therapeutics stock?

Short selling BEAM is an investing strategy that aims to generate trading profit from Beam Therapeutics as its price is falling. BEAM shares are trading up $0.36 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Beam Therapeutics?

A short squeeze for Beam Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BEAM, which in turn drives the price of the stock up even further.

How often is Beam Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BEAM, twice per month. The most recent reporting period available is July, 31 2022.



This page (NASDAQ:BEAM) was last updated on 8/11/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.